Related Experiment Videos
HCV prevalence in methadone maintenance: self-report versus serum test
Michael F Weaver1, Karen L Cropsey, Stephanie A Fox
1Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA, USA. mfweaver@vcu.edu
American Journal of Health Behavior
|October 6, 2005
Summary
Methadone maintenance treatment patients show a significant discrepancy in reported versus tested hepatitis C virus (HCV) status. Many HCV-positive patients engage in risky behaviors, highlighting the need for HCV education.
Area of Science:
- Hepatology
- Infectious Diseases
- Public Health
Background:
- Hepatitis C virus (HCV) infection is a significant concern within vulnerable populations.
- Methadone maintenance treatment (MMT) programs serve individuals at higher risk for HCV infection.
Purpose of the Study:
- To determine the prevalence of HCV infection among MMT patients.
- To identify risk factors associated with HCV infection in this population.
- To assess the patients' desire for HCV-related education.
Main Methods:
- A survey was conducted with 200 MMT patients.
- Medical charts were reviewed for an additional 276 MMT patients.
- Data collected included self-reported HCV serostatus and risk factor assessment.
Main Results:
- Self-reported HCV seroprevalence was 34%, while chart review indicated 70% seroprevalence.
- A substantial proportion of participants reported risk factors for HCV transmission.
- The discrepancy suggests underreporting or lack of awareness of HCV status.
Conclusions:
- There is a notable underestimation of HCV seroprevalence based on self-report compared to serological testing in MMT patients.
- Some HCV-positive MMT patients engage in behaviors that can transmit the virus and may not disclose their status.
- MMT patients express a clear need and desire for comprehensive HCV education.